Basic Information
Basic information for LINC00662-262-20aa-4
Peptide Name LINC00662-262-20aa-4
Genome Position chr19:27730245-27730304[-]
Species Human
Peptide Sequence MFCHVWIHLTELNLCFDSSV
Peptide Length 20
Unique No (LINC00662-224-20aa-1,LINC00662-230-20aa-3,LINC00662-245-20aa-3,LINC00662-257-20aa-3,LINC00662-268-20aa-2)
Grand Average of Hydropathicity 0.835
Relative Molecular Mass 2737.12
Experimental Evidences 2:m6A,ribo
lncRNA ID/Name ENSG00000261824;LINC00662
Transcript ID/Name ENST00000666734;LINC00662-262
Transcript Length 4005
Coding Ability 0.3838
DNA Sequence Corresponding to Peptide ATGTTTTGTCATGTGTGGATTCATCTCACAGAGTTAAACCTTTGTTTTGATTCATCTGTT
Experimental Evidences
   m6A
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :